Research and Markets (http://www.researchandmarkets.com/research/lmx4bb/opportunityanalyze) has announced the addition of the "2013 Report on the International Nonalcoholic Steatohepatitis (NASH) Market - Opportunity Analysis and Forecasts to 2017" report to their offering.
The Nonalcoholic Steatohepatitis (NASH) market is currently deserted and awaits its first NASH-specific therapy. With novel mechanism of action awaiting approval such as: Genfit's PPAR agonist, GFT505 and Intercept Pharmaceuticals/Dainippon Sumitomo Pharma's FXR agonist, Obeticholic Acid. These compounds will race to be the first approved therapy thus claiming first in class.
Scope
- Overview of NASH, including epidemiology, etiology, symptoms, diagnosis, pathology and disease management.
- Analysis of the current and future market competition in the global NASH therapeutics market.
- Pipeline analysis: comprehensive data split across Phase II/IIb, emerging trends and mechanisms of action under development, including: oral Proliferator Activated Receptor alpha, delta (PPARa,d) agonist, oral Farnesoid X Receptor (FXR) agonist, subcutaneous Lysyl Oxidase-Like 2 (LOXL2) inhibitor and subcutaneous Glucagon-like Peptide-1 (GLP-1) agonist.
- Annualized NASH therapeutics market forecast, annual cost of therapy and treatment usage pattern data from 2012-2017.
- Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide qualitative analysis of its implications.
-
Key topics covered include strategic clinical and commercial
benchmarking assessment of the pipeline and standard of care, market
outlook, R&D strategies, and unmet needs for the NASH therapeutics
market.
Key Topics Covered:
1 List of Tables and Figures
2 Introduction
3 Disease Overview
4 Epidemiology
5 Current Treatment Options
6 Unmet Needs Assessment and Opportunity Analysis
7 R&D Strategies
8 Pipeline Assessment
9 Pipeline Valuation Analysis
10 Appendix
For more information visit http://www.researchandmarkets.com/research/lmx4bb/opportunityanalyze
Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S.
Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals